Article Details
Retrieved on: 2024-03-21 18:11:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LABP stock results show that Landos Biopharma missed analyst estimates for earnings per share the fourth quarter of 2023.
Article found on: investorplace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here